Friday, November 28, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

AMN Healthcare Stock: A Battlefield for Bulls and Bears

Andreas Sommer by Andreas Sommer
November 27, 2025
in Analysis, Healthcare, Trading & Momentum
0
AMN Healthcare Services Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

AMN Healthcare Services Inc. shares experienced notable downward pressure in the latest session, closing at $17.22 after a decline of 1.54%. However, this daily loss obscures a more complex narrative unfolding for the healthcare staffing provider. A significant surge in short interest contrasts with a respectable two-week gain of 7.16%, setting the stage for a potential clash between optimistic and pessimistic investors.

Short Sellers Ramp Up Their Bets

Market participants with a bearish outlook are increasingly targeting AMN Healthcare. Data current until November 14 reveals that short interest jumped by 10.56%, reaching 2.57 million shares. This volume equates to 6.76% of the company’s freely tradable stock, creating a scenario ripe with the potential for a short squeeze. Key metrics include:

  • Shares Sold Short: 2.57 million
  • Percentage of Free Float: 6.76%
  • Days to Cover: 1.6 days
  • Recent Change: +10.56%

The notably low “days to cover” metric of just 1.6 suggests that even modest positive developments could trigger a sharp upward move as short sellers scramble to close their positions.

Quarterly Results Present a Mixed Picture

The company’s recent financial report, released on November 6, provided investors with conflicting signals. On one hand, AMN Healthcare delivered a substantial earnings beat. Its adjusted earnings per share came in at $0.39, dramatically surpassing the consensus estimate of $0.19. On the other hand, this figure represents a 36.1% decrease compared to the same period last year. Revenue told a similar story, landing at $634.5 million. While this exceeded analyst forecasts by 3.2%, it was 7.7% lower than the previous year’s result.

Should investors sell immediately? Or is it worth buying AMN Healthcare Services?

Daily Slump Contrasts with Broader Recovery

During yesterday’s trading, the stock underwent a noticeable pullback. It moved within a range of $17.22 to $17.55, indicating active trading interest despite ending the day in negative territory. An interesting point for market observers is the trading volume, which fell by 131,000 shares to a total of 647,000. This could potentially signal a reduction in selling pressure.

This daily setback, however, occurs within the context of a more encouraging short-term trend. Over a fortnight, the equity has managed to secure a solid 7.16% advance.

The central question for investors now is whether AMN Healthcare is embarking on a genuine trend reversal or if the recent uptick is merely a temporary rally within a longer-term downward trajectory. The building short interest clearly reflects market skepticism, while the better-than-expected quarterly figures and the two-week performance offer a foundation for hope.

Ad

AMN Healthcare Services Stock: Buy or Sell?! New AMN Healthcare Services Analysis from November 28 delivers the answer:

The latest AMN Healthcare Services figures speak for themselves: Urgent action needed for AMN Healthcare Services investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 28.

AMN Healthcare Services: Buy or sell? Read more here...

Tags: AMN Healthcare Services
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Lynas Stock
Analysis

Power Grid Failures Plunge Lynas Rare Earths Into Operational Crisis

November 28, 2025
Pfizer Stock
Analysis

Is Pfizer Stock Poised for a Rebound? Obesity Drugs Spark Renewed Optimism

November 28, 2025
MP Materials Stock
Automotive & E-Mobility

MP Materials Shares Surge on Major Electric Vehicle Supply Agreement

November 28, 2025
Next Post
Oaktree Specialty Lending Stock

Oaktree Specialty Lending: Can the Dividend Survive the Downturn?

Viad Stock

Viad Shares Maintain Upward Trajectory on Strong Performance

Grupo Supervielle Stock

Supervielle's Contradiction: Strong Growth Amid Argentina's Banking Crisis

Recommended

Glimpse Stock

Glimpse Group Shares Face Pivotal Week with Fiscal Year Results

2 months ago
Delta Air Lines Stock

Delta Air Lines Navigates Strategic Shift Amid Steady Dividend Payouts

2 months ago
Nvidia Stock

Nvidia’s Earnings: A Defining Moment for the AI Sector

2 weeks ago
Laboratory of America Stock

Laboratory Corp. of America Gains Momentum with Strong Earnings and Strategic Moves

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

MP Materials Shares Surge on Major Electric Vehicle Supply Agreement

BioNTech Faces Critical Juncture Amid Leadership Share Sales

Microsoft’s AI Ambitions Confront Physical Reality

Uranium Energy Stock: A Critical Juncture Approaches

Nike Stock: A Clash of Titans Creates Investor Dilemma

Wolfspeed Shares Signal Potential Recovery Phase

Trending

Lynas Stock
Analysis

Power Grid Failures Plunge Lynas Rare Earths Into Operational Crisis

by Felix Baarz
November 28, 2025
0

Lynas Rare Earths, a critical Western supplier of strategically important minerals, faces an operational emergency completely unrelated...

IBM Stock

IBM’s Strategic Surge: A Multi-Billion Dollar Transformation

November 28, 2025
Pfizer Stock

Is Pfizer Stock Poised for a Rebound? Obesity Drugs Spark Renewed Optimism

November 28, 2025
MP Materials Stock

MP Materials Shares Surge on Major Electric Vehicle Supply Agreement

November 28, 2025
BioNTech Stock

BioNTech Faces Critical Juncture Amid Leadership Share Sales

November 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Power Grid Failures Plunge Lynas Rare Earths Into Operational Crisis
  • IBM’s Strategic Surge: A Multi-Billion Dollar Transformation
  • Is Pfizer Stock Poised for a Rebound? Obesity Drugs Spark Renewed Optimism

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com